Smell tests don't predict Alzheimer's, study finds

May 11, 2012
Smell tests don't predict alzheimer's, study finds
Misleading reports may create false hope -- or false alarm.

(HealthDay) -- Smell tests should not be used to predict Alzheimer's disease, the most common form of dementia, according to a new study.

Although there is a link between the two, researchers found other may cause people to lose their , and it may not necessarily mean they will develop the progressive brain disorder later in life.

"A nonspecific association between poor smell function and Alzheimer's dementia is not the same as actually being able to use a smell test to predict Alzheimer's," Dr. Gordon Sun, a general at the University of Michigan in Ann Arbor, said in a university news release.

"Unfortunately, this of the research has led to the promotion of these tests by the media and public figures like Dr. Oz," he added. "This study helps set the record straight about where the evidence currently stands."

In conducting the comprehensive review, the study's authors examined nearly 1,200 articles dating back to 1984. Two studies that tracked patients over time and 30 studies that evaluated patients at one specific point in time met inclusion criteria.

"Understandably, researchers, clinicians and the public are eager for a simple, accurate, and inexpensive way to predict or diagnose Alzheimer's early, but we're not there yet," argued Sun, who is also a Robert Wood Johnson Foundation/U.S. Veterans Affairs Clinical Scholar at the University of Michigan Medical School.

"My concern is that by promoting smell tests at this point, we create false hope or even false alarm among seniors and their families," he said. "Additional research is needed before we can rely on smell tests to predict the later onset of Alzheimer's."

The study, published online May 10 in the journal , concluded that patients visit their primary care physician if they are concerned about their risk for Alzheimer's disease.

About 5.4 million Americans have Alzheimer's disease, most of them aged 65 and older, according to the Alzheimer's Association. That number is expected to rise rapidly as the Baby Boomer generation ages.

Explore further: Early-onset Alzheimer's not always associated with memory loss

More information: The U.S. National Institute on Aging provides more information on Alzheimer's disease.

Related Stories

Early-onset Alzheimer's not always associated with memory loss

May 19, 2011
(Medical Xpress) -- In a recent study published in the journal Neurology, scientists say that individuals who develop early-onset Alzheimer's in middle age are at a high risk of being misdiagnosed because many of their initial ...

New clues to the cause of Alzheimer's disease

June 30, 2011
Researchers at the Sahlgrenska Academy, University of Gothenburg, have identified a series of novel proteins in human cerebrospinal fluid. The proteins, which carry specific sugar molecules, are found in greater concentrations ...

Test for Alzheimer's disease predicts cognitive decline in Parkinson's disease

December 12, 2011
A method of classifying brain atrophy patterns in Alzheimer's disease patients using MRIs can also detect cognitive decline in Parkinson's disease, according to a new study by researchers from the Perelman School of Medicine ...

Recommended for you

Rocky start for Alzheimer's drug research in 2018

January 19, 2018
The year 2018, barely underway, has already dealt a series of disheartening blows to the quest for an Alzheimer's cure.

Alzheimer's disease: Neuronal loss very limited

January 17, 2018
Frequently encountered in the elderly, Alzheimer's is considered a neurodegenerative disease, which means that it is accompanied by a significant, progressive loss of neurons and their nerve endings, or synapses. A joint ...

Anxiety: An early indicator of Alzheimer's disease?

January 12, 2018
A new study suggests an association between elevated amyloid beta levels and the worsening of anxiety symptoms. The findings support the hypothesis that neuropsychiatric symptoms could represent the early manifestation of ...

One of the most promising drugs for Alzheimer's disease fails in clinical trials

January 11, 2018
To the roughly 400 clinical trials that have tested some experimental treatment for Alzheimer's disease and come up short, we can now add three more.

Different disease types associated with distinct amyloid-beta prion strains found in Alzheimer's patients

January 9, 2018
An international team of researchers has found different disease type associations with distinct amyloid-beta prion strains in the brains of dead Alzheimer's patients. In their paper published in Proceedings of the National ...

Advances in brain imaging settle debate over spread of key protein in Alzheimer's

January 5, 2018
Recent advances in brain imaging have enabled scientists to show for the first time that a key protein which causes nerve cell death spreads throughout the brain in Alzheimer's disease - and hence that blocking its spread ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.